The Diagnostic Value of Stool-Based MicroRNA-135b in the Early Detection of Colorectal Cancer and the Potent Neuro Function of MiR-146a

Juan Peng

doi:10.62051/tdx3ae98

Authors

Juan Peng

DOI:

https://doi.org/10.62051/tdx3ae98

Keywords:

miRNA, colorectal cancer, meta-analysis, gene expression, biomarkers, non-invasive.

Abstract

Background: Detecting microRNA (miRNA) in stool is a non-invasive approach for colorectal cancer (CRC) screening. This study aims to assess the diagnostic performance of stool-based microRNA-135b in detection of colorectal cancer and the role of miR-146a. Methods: To identify eligible studies that are well suited for diagnostic value of miR-135b in stool of colorectal cancer patients, we have evaluated 3 papers after systematic literature search of public database. The sensitivity and specificity were used to plot the summary receiver operator characteristic (SROC) curve and calculate the area under the SROC curve (AUC). The between-study heterogeneity was evaluated by Q test and I2 statistics. Importantly, we have also identified microRNA (miRNA) gene expression patterns by expression profiling. Moreover, we execute the pathway analysis to find the function of miR-146a. Results: A total of 3 studies from 19 articles were included for the meta-analysis according to the inclusion criteria. The overall analysis showed that microRNA-135b has a relatively good diagnostic performance in colorectal cancer, with a sensitivity of 0.685, a specificity of 0.813 and a partial AUC of 0.658. In stool samples, level of microRNA-135b was 2.21 fold change higher in subjects with CRC (P < 0.0001). Moreover, our study proved that miR-146a involved in the neuro and immune function. Interpretation: In conclusion, stool-based microRNA-135b shows a moderate level of overall diagnostic accuracy in diagnosis of CRC, which may present as auxiliary means for the diagnosis of colorectal cancer compare with colonoscopy. Further large-scale prospective studies are necessary to validate their potential applicability (miR-135b and miR-146a) combined with FBT methods in human cancer diagnosis.

Downloads

Download data is not yet available.

References

Ahmed, F. E., Ahmed, N. C., Vos, P. W., Bonnerup, C., Atkins, J. N., Casey, M., Nuovo, G. J., Naziri, W., Wiley, J. E., Mota, H. & Allison, R. R. (2013), "Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle", Cancer Genomics Proteomics, Vol. 10 No. 3, pp. 93-113.

Aslam, M. I., Hussein, S., West, K., Singh, B., Jameson, J. S. & Pringle, J. H. (2015), "MicroRNAs associated with initiation and progression of colonic polyp: a feasibility study", Int J Surg, Vol. 13272-279.

Berindan-Neagoe, I., Monroig, P. C., Pasculli, B. & Calin, G. A. (2014), "MicroRNAome genome: a treasure for cancer diagnosis and therapy", CA Cancer J Clin, Vol. 64 No. 5, pp. 311-36.

Chai, Z., Fan, H., Li, Y., Song, L., Jin, X., Yu, J., Li, Y., Ma, C. & Zhou, R. (2017), "miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis", Oncol Rep, Vol. 38 No. 5, pp. 2717-2726.

Du M, Liu, B., Li, M., Cao, J., Liu, D., Wang, Z., Wang, Q., Xiao, P., Zhang, X., Gao, Y., Zeng, H., Yang, J., Xu, X., Huang, Y., Zhang, Q., Zhang, B., Chen, W., Shi, J., Fan, S., Zhang, F., Yang, J., Yang, H., Ding, Z., Li, H., Xiao, S., Ran, S., Zhai, H., Wang, F., Xing, Y., Suo, J. & Liu, Y. (2019), "Multicenter surveillance study of surgical site infection and its risk factors in radical resection of colon or rectal carcinoma", BMC Infect Dis, Vol. 19 No. 1, pp. 411.

Faltejskova, P., Svoboda, M., Srutova, K., Mlcochova, J., Besse, A., Nekvindova, J., Radova, L., Fabian, P., Slaba, K., Kiss, I., Vyzula, R. & Slaby, O. (2012), "Identification and functional screening of microRNAs highly deregulated in colorectal cancer", J Cell Mol Med, Vol. 16 No. 11, pp. 2655-66.

Fetahu, I. S., Tennakoon, S., Lines, K. E., Groschel, C., Aggarwal, A., Mesteri, I., Baumgartner-Parzer, S., Mader, R. M., Thakker, R. V. & Kallay, E. (2016), "miR-135b- and miR-146b-dependent silencing of calcium-sensing receptor expression in colorectal tumors", Int J Cancer, Vol. 138 No. 1, pp. 137-45.

Hu, S., Dong, T. S., Dalal, S. R., Wu, F., Bissonnette, M., Kwon, J. H. & Chang, E. B. (2011), "The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer", PLoS One, Vol. 6 No. 1, pp. e16221.

Khatri, R. & Subramanian, S. (2013), "MicroRNA-135b and Its Circuitry Networks as Potential Therapeutic Targets in Colon Cancer", Front Oncol, Vol. 3268.

Kopke, S., Buhrke, T. & Lampen, A. (2015), "miRNA expression in human intestinal Caco-2 cells is comparably regulated by cis- and trans-fatty acids", Lipids, Vol. 50 No. 3, pp. 227-39.

Kottorou, A. E., Antonacopoulou, A. G., Dimitrakopoulos, F. D., Diamantopoulou, G., Sirinian, C., Kalofonou, M., Theodorakopoulos, T., Oikonomou, C., Katsakoulis, E. C., Koutras, A., Makatsoris, T., Demopoulos, N., Stephanou, G., Stavropoulos, M., Thomopoulos, K. C. & Kalofonos, H. P. (2018), "Deregulation of methylation of transcribed-ultra conserved regions in colorectal cancer and their value for detection of adenomas and adenocarcinomas", Oncotarget, Vol. 9 No. 30, pp. 21411-21428.

Li, P., Fan, J. B., Gao, Y., Zhang, M., Zhang, L., Yang, N. & Zhao, X. (2016), "miR-135b-5p inhibits LPS-induced TNFalpha production via silencing AMPK phosphatase Ppm1e", Oncotarget, Vol. 7 No. 47, pp. 77978-77986.

Li, S. H., Li, J. P., Chen, L. & Liu, J. L. (2018), "miR-146a induces apoptosis in neuroblastoma cells by targeting BCL11A", Med Hypotheses, Vol. 11721-27.

Link, A., Balaguer, F., Shen, Y., Nagasaka, T., Lozano, J. J., Boland, C. R. & Goel, A. (2010), "Fecal MicroRNAs as novel biomarkers for colon cancer screening", Cancer Epidemiol Biomarkers Prev, Vol. 19 No. 7, pp. 1766-74.

Meyerhardt, J. A. (2011), "Beyond standard adjuvant therapy for colon cancer: role of nonstandard interventions", Semin Oncol, Vol. 38 No. 4, pp. 533-41.

Nguyen, L. S., Fregeac, J., Bole-Feysot, C., Cagnard, N., Iyer, A., Anink, J., Aronica, E., Alibeu, O., Nitschke, P. & Colleaux, L. (2018), "Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders", Mol Autism, Vol. 938.

Valeri, N., Braconi, C., Gasparini, P., Murgia, C., Lampis, A., Paulus-Hock, V., Hart, J. R., Ueno, L., Grivennikov, S. I., Lovat, F., Paone, A., Cascione, L., Sumani, K. M., Veronese, A., Fabbri, M., Carasi, S., Alder, H., Lanza, G., Gafa', R., Moyer, M. P., Ridgway, R. A., Cordero, J., Nuovo, G. J., Frankel, W. L., Rugge, M., Fassan, M., Groden, J., Vogt, P. K., Karin, M., Sansom, O. J. & Croce, C. M. (2014a), "MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer", Cancer Cell, Vol. 25 No. 4, pp. 469-83.

Zekri, A. R., Youssef, A. S., Lotfy, M. M., Gabr, R., Ahmed, O. S., Nassar, A., Hussein, N., Omran, D., Medhat, E., Eid, S., Hussein, M. M., Ismail, M. Y., Alenzi, F. Q. & Bahnassy, A. A. (2016), "Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer", PLoS One, Vol. 11 No. 5, pp. e0154130.

Zhang, Y., Xing, H., Guo, S., Zheng, Z., Wang, H. & Xu, D. (2016), "MicroRNA-135b has a neuroprotective role via targeting of beta-site APP-cleaving enzyme 1", Exp Ther Med, Vol. 12 No. 2, pp. 809-814.

Zhou, W., Li, X., Liu, F., Xiao, Z., He, M., Shen, S. & Liu, S. (2012a), "MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro", Acta Biochim Biophys Sin (Shanghai), Vol. 44 No. 10, pp. 838-46.

Yongdong, P., Studies on the effects of miR-224,miR-146b,miR-215 and miR-135a on preadipocyte differentiation and lipid metabolism. 2014,HuaZhong Agriculture University. p. 135.